4.4 Article

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Journal

JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
Volume -, Issue 140, Pages -

Publisher

JOURNAL OF VISUALIZED EXPERIMENTS
DOI: 10.3791/58382

Keywords

Medicine; Issue 140; Machine learning; artificial intelligence; interventional radiology; hepatocellular carcinoma; trans-arterial chemoembolization; supervised machine learning; predictive modeling; predicting outcomes; pre-procedure planning

Funding

  1. Office of Student Research, Yale School of Medicine
  2. Leopoldina Postdoctoral Fellowship
  3. Rolf W. Guenther Foundation of Radiological Sciences (Aachen, Germany)
  4. Philips Healthcare
  5. German-Israeli Foundation for Scientific Research and Development (Jerusalem, Israel)
  6. German-Israeli Foundation for Scientific Research and Development (Neuherberg, Germany)
  7. Rolf W. Guenther Foundation of Radiological Sciences
  8. Charite Berlin Institute of Health Clinical Scientist Program (Berlin, Germany)
  9. Philips Healthcare (Best, The Netherlands)
  10. National Institutes of Health [NIH/NCI R01CA206180]
  11. BTG (London, United Kingdom)
  12. Boston Scientific (Marlborough, Massachusetts)
  13. Guerbet Healthcare (Villepinte, France)

Ask authors/readers for more resources

Intra-arterial therapies are the standard of care for patients with hepatocellular carcinoma who cannot undergo surgical resection. The objective of this study was to develop a method to predict response to intra-arterial treatment prior to intervention. The method provides a general framework for predicting outcomes prior to intra-arterial therapy. It involves pooling clinical, demographic and imaging data across a cohort of patients and using these data to train a machine learning model. The trained model is applied to new patients in order to predict their likelihood of response to intra-arterial therapy. The method entails the acquisition and parsing of clinical, demographic and imaging data from N patients who have already undergone transarterial therapies. These data are parsed into discrete features (age, sex, cirrhosis, degree of tumor enhancement, etc.) and binarized into true/ false values (e.g., age over 60, male gender, tumor enhancement beyond a set threshold, etc.). Low-variance features and features with low univariate associations with the outcome are removed. Each treated patient is labeled according to whether they responded or did not respond to treatment. Each training patient is thus represented by a set of binary features and an outcome label. Machine learning models are trained using N - 1 patients with testing on the left-out patient. This process is repeated for each of the N patients. The N models are averaged to arrive at a final model. The technique is extensible and enables inclusion of additional features in the future. It is also a generalizable process that may be applied to clinical research questions outside of interventional radiology. The main limitation is the need to derive features manually from each patient. A popular modern form of machine learning called deep learning does not suffer from this limitation, but requires larger datasets.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available